Sanofi Starts Dengue Vaccine Production to Keep Lead Over Rivals

Sanofi has begun mass-producing a dengue vaccine that the company has been working on for 20 years. Dengue is a tropical infection with no real cure that is endemic in many parts of the world. Sanofi says that it may be able to produce 100 million doses of the vaccine per year.
Reuters